A CTNNA3 compound heterozygous deletion implicates a role for αt-catenin in susceptibility to autism spectrum disorder

Elena Bacchelli, Fabiola Ceroni, Dalila Pinto, Silvia Lomartire, Maila Giannandrea, Patrizia D'Adamo, Elena Bonora, Piero Parchi, Raffaella Tancredi, Agatino Battaglia, Elena Maestrini

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Autism spectrum disorder (ASD) is a highly heritable, neurodevelopmental condition showing extreme genetic heterogeneity. While it is well established that rare genetic variation, both de novo and inherited, plays an important role in ASD risk, recent studies also support a rare recessive contribution. Methods: We identified a compound heterozygous deletion intersecting the CTNNA3 gene, encoding αT-catenin, in a proband with ASD and moderate intellectual disability. The deletion breakpoints were mapped at base-pair resolution, and segregation analysis was performed. We compared the frequency of CTNNA3 exonic deletions in 2,147 ASD cases from the Autism Genome Project (AGP) study versus the frequency in 6,639 controls. Western blot analysis was performed to get a quantitative characterisation of Ctnna3 expression during early brain development in mouse. Results: The CTNNA3 compound heterozygous deletion includes a coding exon, leading to a putative frameshift and premature stop codon. Segregation analysis in the family showed that the unaffected sister is heterozygote for the deletion, having only inherited the paternal deletion. While the frequency of CTNNA3 exonic deletions is not significantly different between ASD cases and controls, no homozygous or compound heterozygous exonic deletions were found in a sample of over 6,000 controls. Expression analysis of Ctnna3 in the mouse cortex and hippocampus (P0-P90) provided support for its role in the early stage of brain development. Conclusion: The finding of a rare compound heterozygous CTNNA3 exonic deletion segregating with ASD, the absence of CTNNA3 homozygous exonic deletions in controls and the high expression of Ctnna3 in both brain areas analysed implicate CTNNA3 in ASD susceptibility.

Original languageEnglish
Article number17
JournalJournal of Neurodevelopmental Disorders
Volume6
Issue number1
DOIs
Publication statusPublished - Jul 10 2014

Fingerprint

Catenins
Brain
Genetic Heterogeneity
Nonsense Codon
Heterozygote
Autistic Disorder
Autism Spectrum Disorder
Base Pairing
Intellectual Disability
Exons
Hippocampus
Western Blotting
Genome
Genes

Keywords

  • Alpha T-catenin
  • Autism spectrum disorder (ASD)
  • Cell adhesion
  • CTNNA3
  • DNA copy number variants
  • αT-catenin

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Cognitive Neuroscience
  • Pediatrics, Perinatology, and Child Health

Cite this

A CTNNA3 compound heterozygous deletion implicates a role for αt-catenin in susceptibility to autism spectrum disorder. / Bacchelli, Elena; Ceroni, Fabiola; Pinto, Dalila; Lomartire, Silvia; Giannandrea, Maila; D'Adamo, Patrizia; Bonora, Elena; Parchi, Piero; Tancredi, Raffaella; Battaglia, Agatino; Maestrini, Elena.

In: Journal of Neurodevelopmental Disorders, Vol. 6, No. 1, 17, 10.07.2014.

Research output: Contribution to journalArticle

Bacchelli, Elena ; Ceroni, Fabiola ; Pinto, Dalila ; Lomartire, Silvia ; Giannandrea, Maila ; D'Adamo, Patrizia ; Bonora, Elena ; Parchi, Piero ; Tancredi, Raffaella ; Battaglia, Agatino ; Maestrini, Elena. / A CTNNA3 compound heterozygous deletion implicates a role for αt-catenin in susceptibility to autism spectrum disorder. In: Journal of Neurodevelopmental Disorders. 2014 ; Vol. 6, No. 1.
@article{0b04c8d437494cbfb94e47a0ce783a67,
title = "A CTNNA3 compound heterozygous deletion implicates a role for αt-catenin in susceptibility to autism spectrum disorder",
abstract = "Background: Autism spectrum disorder (ASD) is a highly heritable, neurodevelopmental condition showing extreme genetic heterogeneity. While it is well established that rare genetic variation, both de novo and inherited, plays an important role in ASD risk, recent studies also support a rare recessive contribution. Methods: We identified a compound heterozygous deletion intersecting the CTNNA3 gene, encoding αT-catenin, in a proband with ASD and moderate intellectual disability. The deletion breakpoints were mapped at base-pair resolution, and segregation analysis was performed. We compared the frequency of CTNNA3 exonic deletions in 2,147 ASD cases from the Autism Genome Project (AGP) study versus the frequency in 6,639 controls. Western blot analysis was performed to get a quantitative characterisation of Ctnna3 expression during early brain development in mouse. Results: The CTNNA3 compound heterozygous deletion includes a coding exon, leading to a putative frameshift and premature stop codon. Segregation analysis in the family showed that the unaffected sister is heterozygote for the deletion, having only inherited the paternal deletion. While the frequency of CTNNA3 exonic deletions is not significantly different between ASD cases and controls, no homozygous or compound heterozygous exonic deletions were found in a sample of over 6,000 controls. Expression analysis of Ctnna3 in the mouse cortex and hippocampus (P0-P90) provided support for its role in the early stage of brain development. Conclusion: The finding of a rare compound heterozygous CTNNA3 exonic deletion segregating with ASD, the absence of CTNNA3 homozygous exonic deletions in controls and the high expression of Ctnna3 in both brain areas analysed implicate CTNNA3 in ASD susceptibility.",
keywords = "Alpha T-catenin, Autism spectrum disorder (ASD), Cell adhesion, CTNNA3, DNA copy number variants, αT-catenin",
author = "Elena Bacchelli and Fabiola Ceroni and Dalila Pinto and Silvia Lomartire and Maila Giannandrea and Patrizia D'Adamo and Elena Bonora and Piero Parchi and Raffaella Tancredi and Agatino Battaglia and Elena Maestrini",
year = "2014",
month = "7",
day = "10",
doi = "10.1186/1866-1955-6-17",
language = "English",
volume = "6",
journal = "Journal of Neurodevelopmental Disorders",
issn = "1866-1947",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - A CTNNA3 compound heterozygous deletion implicates a role for αt-catenin in susceptibility to autism spectrum disorder

AU - Bacchelli, Elena

AU - Ceroni, Fabiola

AU - Pinto, Dalila

AU - Lomartire, Silvia

AU - Giannandrea, Maila

AU - D'Adamo, Patrizia

AU - Bonora, Elena

AU - Parchi, Piero

AU - Tancredi, Raffaella

AU - Battaglia, Agatino

AU - Maestrini, Elena

PY - 2014/7/10

Y1 - 2014/7/10

N2 - Background: Autism spectrum disorder (ASD) is a highly heritable, neurodevelopmental condition showing extreme genetic heterogeneity. While it is well established that rare genetic variation, both de novo and inherited, plays an important role in ASD risk, recent studies also support a rare recessive contribution. Methods: We identified a compound heterozygous deletion intersecting the CTNNA3 gene, encoding αT-catenin, in a proband with ASD and moderate intellectual disability. The deletion breakpoints were mapped at base-pair resolution, and segregation analysis was performed. We compared the frequency of CTNNA3 exonic deletions in 2,147 ASD cases from the Autism Genome Project (AGP) study versus the frequency in 6,639 controls. Western blot analysis was performed to get a quantitative characterisation of Ctnna3 expression during early brain development in mouse. Results: The CTNNA3 compound heterozygous deletion includes a coding exon, leading to a putative frameshift and premature stop codon. Segregation analysis in the family showed that the unaffected sister is heterozygote for the deletion, having only inherited the paternal deletion. While the frequency of CTNNA3 exonic deletions is not significantly different between ASD cases and controls, no homozygous or compound heterozygous exonic deletions were found in a sample of over 6,000 controls. Expression analysis of Ctnna3 in the mouse cortex and hippocampus (P0-P90) provided support for its role in the early stage of brain development. Conclusion: The finding of a rare compound heterozygous CTNNA3 exonic deletion segregating with ASD, the absence of CTNNA3 homozygous exonic deletions in controls and the high expression of Ctnna3 in both brain areas analysed implicate CTNNA3 in ASD susceptibility.

AB - Background: Autism spectrum disorder (ASD) is a highly heritable, neurodevelopmental condition showing extreme genetic heterogeneity. While it is well established that rare genetic variation, both de novo and inherited, plays an important role in ASD risk, recent studies also support a rare recessive contribution. Methods: We identified a compound heterozygous deletion intersecting the CTNNA3 gene, encoding αT-catenin, in a proband with ASD and moderate intellectual disability. The deletion breakpoints were mapped at base-pair resolution, and segregation analysis was performed. We compared the frequency of CTNNA3 exonic deletions in 2,147 ASD cases from the Autism Genome Project (AGP) study versus the frequency in 6,639 controls. Western blot analysis was performed to get a quantitative characterisation of Ctnna3 expression during early brain development in mouse. Results: The CTNNA3 compound heterozygous deletion includes a coding exon, leading to a putative frameshift and premature stop codon. Segregation analysis in the family showed that the unaffected sister is heterozygote for the deletion, having only inherited the paternal deletion. While the frequency of CTNNA3 exonic deletions is not significantly different between ASD cases and controls, no homozygous or compound heterozygous exonic deletions were found in a sample of over 6,000 controls. Expression analysis of Ctnna3 in the mouse cortex and hippocampus (P0-P90) provided support for its role in the early stage of brain development. Conclusion: The finding of a rare compound heterozygous CTNNA3 exonic deletion segregating with ASD, the absence of CTNNA3 homozygous exonic deletions in controls and the high expression of Ctnna3 in both brain areas analysed implicate CTNNA3 in ASD susceptibility.

KW - Alpha T-catenin

KW - Autism spectrum disorder (ASD)

KW - Cell adhesion

KW - CTNNA3

KW - DNA copy number variants

KW - αT-catenin

UR - http://www.scopus.com/inward/record.url?scp=84952871619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952871619&partnerID=8YFLogxK

U2 - 10.1186/1866-1955-6-17

DO - 10.1186/1866-1955-6-17

M3 - Article

AN - SCOPUS:84952871619

VL - 6

JO - Journal of Neurodevelopmental Disorders

JF - Journal of Neurodevelopmental Disorders

SN - 1866-1947

IS - 1

M1 - 17

ER -